Evidence map›Paper›PMID 40674746›Full record

ArticleJMIR formative research2025

Performance of a Retinal Imaging Camera With On-Device Intelligence for Primary Care: Retrospective Study.

Matthew Silvestrini, Clarissa Lui, Anil Patwardhan, Ying Chen, Tayyeba Ali, Elie Glik, Honglei Wu, Brian Levinstein, Adrianna Wenz, Nathan Shemonski and 3 more

Abstract read
In one paragraph

Article in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Matthew Silvestrini *Verily Life Sciences, 999 Bayhill Dr, San Bruno, CA, 94066, United States, 1 415-786-7939.ORCID 0009-0006-6891-5188
Clarissa Lui *Verily Life Sciences, 999 Bayhill Dr, San Bruno, CA, 94066, United States, 1 415-786-7939.ORCID 0009-0003-7611-5744
Anil PatwardhanVerily Life Sciences, 999 Bayhill Dr, San Bruno, CA, 94066, United States, 1 415-786-7939.ORCID 0009-0000-2816-7142
Ying ChenVerily Life Sciences, 999 Bayhill Dr, San Bruno, CA, 94066, United States, 1 415-786-7939.ORCID 0009-0007-7743-8675
Tayyeba AliVerily Life Sciences, 999 Bayhill Dr, San Bruno, CA, 94066, United States, 1 415-786-7939.ORCID 0000-0003-3192-7821
Elie GlikVerily Life Sciences, 999 Bayhill Dr, San Bruno, CA, 94066, United States, 1 415-786-7939.ORCID 0009-0007-7688-4796
Honglei WuVerily Life Sciences, 999 Bayhill Dr, San Bruno, CA, 94066, United States, 1 415-786-7939.ORCID 0009-0006-2868-096X
Brian LevinsteinVerily Life Sciences, 999 Bayhill Dr, San Bruno, CA, 94066, United States, 1 415-786-7939.ORCID 0009-0007-8084-9045
Adrianna WenzVerily Life Sciences, 999 Bayhill Dr, San Bruno, CA, 94066, United States, 1 415-786-7939.ORCID 0009-0006-6747-2717
Nathan ShemonskiVerily Life Sciences, 999 Bayhill Dr, San Bruno, CA, 94066, United States, 1 415-786-7939.ORCID 0009-0001-6799-6178
Lin YangVerily Life Sciences, 999 Bayhill Dr, San Bruno, CA, 94066, United States, 1 415-786-7939.ORCID 0000-0001-7593-7066
Ian AtkinsonVerily Life Sciences, 999 Bayhill Dr, San Bruno, CA, 94066, United States, 1 415-786-7939.ORCID 0000-0001-6586-4473
Sam KavusiVerily Life Sciences, 999 Bayhill Dr, San Bruno, CA, 94066, United States, 1 415-786-7939.ORCID 0000-0002-8098-1157

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Access to screening continues to be a barrier for the early detection of diabetic retinopathy (DR). Primary care-based diabetic retinopathy screening could improve access, but operational challenges, such as cost and workflow management, hamper the widespread adoption of retinal camera systems in primary care clinics in the United States. Objective: This study aimed to develop and evaluate a retinal screening system suitable for integration into a primary care workflow. Methods: We developed a nonmydriatic, 45° field imaging retinal camera system, the Verily Numetric Retinal Camera (VNRC; Verily Life Sciences LLC), able to generate high-fidelity retinal images enabled by on-device intelligent features. The VNRC output flows into cloud-based software that accepts and routes digitized images for grading. We evaluated the performance and usability of the VNRC in 2 studies. A retrospective performance study compared the performance of VNRC against a reference camera (Crystalvue NFC-700 [Crystalvue Medical]) as well as the correlation between VNRC capture status and gradability (as determined by ophthalmologist graders). The usability study simulated a primary care setting for a combined cohort of trained and untrained users (corresponding to patients in the simulation) and operators (corresponding to health care personnel in the simulation), where respondents completed a questionnaire about their user experience after attempting to capture images with the VNRC. Results: In the comparative performance study (N=108, K=206 images), a total of 98.5% (203/206) of images captured by the VNRC were graded as sufficient for clinical interpretation compared to 97.1% (200/206) of Crystalvue NFC-700 images (difference in proportion was 0.015, 95% CI -0.007 to 0.033). In the quality control algorithm evaluation (N=172, K=343 images), we found a positive association (φ=0.58, 95% CI 0.45-0.69) between gradability status (gradable or nongradable) as determined by ophthalmologists and the capture status (recapture not-needed or needed) as determined by the VNRC quality control algorithm. In the usability study (n=15 users and n=30 operators), all participating users (15/15) indicated that they were able to have both eyes screened easily. Most users and operators indicated agreement (from somewhat agree to strongly agree) with statements describing the imaging process as intuitive (15/15, 100% and 29/30, 97%), comfortable (15/15, 100% and 30/30, 100%), and allowing for a positive experience (15/15, 100% and 30/30, 100%), of users and operators, respectively. Conclusions: Our findings about the performance and usability of this retinal camera system support its deployment as an integrated end-to-end retinal service for primary care. These results warrant additional studies to fully characterize real-world usability across a wider and diverse set of primary care clinics.

Indexed as

Diabetic RetinopathyPhotographyRetinaAdultFemaleHumansMaleMiddle AgedPrimary Health CareRetrospective Studiesdiabetic retinopathydiabetic retinopathy screeningfundus imagingretinal cameraretinal imaging

Identifiers

PMID40674746
PMCPMC12289297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.